PZ0022

BLI-489 hydrate

≥98% (HPLC), β-lactamase inhibitor, powder

• Synonim(y): 6-[(5,6-Dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt hydrate, WAY-185489
• Wzór empiryczny (zapis Hilla): C₁₃H₁₀N₃NaO₄S · xH₂O
• Numer CAS: 2580120-08-5
• Masa cząsteczkowa: 327.29 (anhydrous basis)
• UNSPSC Code: 12352200
• PubChem Substance ID: 329823689
• NACRES: NA.77
• MDL number: MFCD22374169
• Assay: ≥98% (HPLC)
• Form: powder

Właściwości

• Nazwa produktu: BLI-489 hydrate, ≥98% (HPLC)
• assay: ≥98% (HPLC)
• form: powder
• color: yellow
• solubility: H₂O: >20 mg/mL
• storage temp.: room temp
• SMILES string: O=C(N1[C@]/2([H])SC=C1C([O-])=O)C2=C\C3=CN4C(COCC4)=N3.[Na+].O
• InChI: 1S/C13H11N3O4S.Na.H2O/c17-11-8(12-16(11)9(6-21-12)13(18)19)3-7-4-14-10-5-20-2-1-15(7)10;;/h3-4,6,12H,1-2,5H2,(H,18,19);;1H2/q;+1;/p-1/b8-3-;;/t12-;;/m1../s1
• InChI key: UAZCFKAYAYJPDM-UVEQJXRBSA-M

Opis

Biochem/physiol Actions

BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria.

BLI-489 is a penem β-lactamase inhibitor.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 11 - Combustible Solids
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• pictograms: GHS07
• signalword: Warning
• hcodes: H317,H319
• pcodes: P261 - P264 - P272 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Sens. 1